Macrophage stimulation in cd47 blockade therapy

作者: Natasja Nielsen Viller , Robert Adam Uger , Gloria Hoi Ying Lin , Lisa Danae Schultz Johnson , Mark Michael Wong

DOI:

关键词: DrugMacrophageStimulationBlockadeCancer cellCombination therapyCD47MedicinePharmacology

摘要: Blockade of the CD47/SIRPa pathway depletes cancer cells. This anti-cancer activity is enhanced when macrophage stimulating agents are used in combination with CD47 blockade drug. therapy particularly effective drug SIRPaFc.

参考文章(5)
Penka Slavtcheva Slavova-Petrova, Xinli Pang, Robert Adam Uger, Treatment of cd47+ disease cells with sirp alpha-fc fusions ,(2013)
Kipp Weiskopf, Aaron M Ring, Chia Chi M Ho, Jens-Peter Volkmer, Aron M Levin, Anne Kathrin Volkmer, Engin Özkan, Nathaniel B Fernhoff, Matt van de Rijn, Irving L Weissman, K Christopher Garcia, None, Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies Science. ,vol. 341, pp. 88- 91 ,(2013) , 10.1126/SCIENCE.1238856
Alexandre P.A. Theocharides, Liqing Jin, Po-Yan Cheng, Tatiana K. Prasolava, Andrei V. Malko, Jenny M. Ho, Armando G. Poeppl, Nico van Rooijen, Mark D. Minden, Jayne S. Danska, John E. Dick, Jean C.Y. Wang, Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts Journal of Experimental Medicine. ,vol. 209, pp. 1883- 1899 ,(2012) , 10.1084/JEM.20120502
John Dick, Sujeetha Rajakumar, Liqing Jin, Alexandre Theocharides, C. Y. Jean Wang, Jayne Danska, Compositions and methods for treating hematologic cancers targeting the sirp - cd47 interaction ,(2010)
Ravindra Majeti, Emily Piccione Griffin, SIRP alpha-antibody fusion proteins ,(2015)